Published in AIDS Weekly, August 24th, 1998
"We are having very good, durable CTL," said Thomas Evans of the AIDS Vaccine Evaluation Group (AVEG). "At two years it looks like 50 percent [of subjects] will be positive for [CTL specific for] HIV-1 Env or Gag."
Evans presented the data to the 12th World AIDS Conference, held June 28-July 3, 1998, in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.